Actively Recruiting

Age: 18Years +
All Genders
NCT04988685

SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated With SIROlimus Or Paclitaxel Eluting Balloon Catheters

Led by Luzerner Kantonsspital · Updated on 2024-10-29

2000

Participants Needed

1

Research Sites

552 weeks

Total Duration

On this page

Sponsors

L

Luzerner Kantonsspital

Lead Sponsor

U

University Hospital, Geneva

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of the SIROOP Registry is to retrospectively and prospectively collect baseline, clinical and procedural characteristics of patients who have undergone PCI and are treated with either currently available sirolimus or paclitaxel coated DCBs (see Table 1), irrespective of clinical presentation as well as to prospectively collect data about their clinical outcomes. Outcomes will be compared in different clinical subgroups. The impact of current DCBs in different clinical settings and coronary artery lesions on cardiovascular outcomes will be assessed.

CONDITIONS

Official Title

SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated With SIROlimus Or Paclitaxel Eluting Balloon Catheters

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Subject >18 years of age
  • Patients with significant acute or chronic coronary de-novo lesions or ISR lesions requiring treatment using PCI
  • Treatment with at least one DCB (device choice at the operator's discretion) In case of a patient with lesions treated at different procedural time, lesions will be separately collected and documented
  • Subjects must be willing to sign a patient informed consent (PIC) or must have signed the General Consent (GK).
Not Eligible

You will not qualify if you...

  • Patient is <18 years of age
  • Patient unwilling or unable to provide informed consent
  • Pregnancy and lactation
  • Indication for surgical revascularization

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Luzerner Heart Centre

Lucerne, Canton of Lucerne, Switzerland, 6000

Actively Recruiting

Loading map...

Research Team

F

Florim Cuculi, MD

CONTACT

M

Matthias Bossard, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here